Pregnancy SmartShop formulas

Is it safe? · Pregnancy Smart

Phenytoin (Dilantin) During Pregnancy: Fetal Hydantoin Risk

Assigned clinical reviewerMatt Stahl· PharmDDraft · pending clinical reviewUpdated

What does the evidence say about phenytoin during pregnancy?

  1. The current Dilantin label states that prenatal phenytoin exposure is associated with increased major malformations, including oral clefts and cardiac defects, and with fetal hydantoin syndrome. Label-cited observational meta-analyses estimated about a 2.4-fold relative increase versus controls. 1
  2. The 2024 AAN, AES, and SMFM guideline recommends at least 0.4 mg folic acid daily before conception and during pregnancy for anyone taking an antiseizure medicine. It does not support one universal high-dose regimen and notes that folic acid can lower phenytoin concentrations. 2
  3. A comprehensive review found inconsistent major-malformation estimates across phenytoin studies and noted that later work raised concerns about how fetal hydantoin syndrome was defined. This uncertainty does not erase the label warning or establish a no-risk dose. 3
  4. A pregnancy epilepsy review reports a 2.9 percent major congenital-malformation rate for phenytoin in one North American registry analysis, with a relative risk of 1.5 versus lamotrigine and a confidence interval crossing the null; the estimate was limited by fewer phenytoin exposures. 4
  5. The Dilantin label warns that pregnancy can increase phenytoin clearance, making periodic blood-level monitoring useful, and that newborn exposure can be associated with a serious vitamin K-related bleeding disorder requiring planned maternal and neonatal management. 5

Is phenytoin safe in each trimester?

  • First trimester. Major structural development occurs early, so contact the prescribing neurologist as soon as pregnancy is recognized. A medication change after conception is not automatically safer, and abrupt phenytoin withdrawal can lead to more frequent seizures or status epilepticus.
  • Second trimester. Pregnancy can increase phenytoin clearance and lower blood concentrations. The current joint guideline recommends monitoring antiseizure-medication levels according to each drug's pharmacokinetics and the patient's clinical course, with dose changes directed by the clinician.
  • Third trimester. Phenytoin clearance can remain altered late in pregnancy and return toward baseline after birth. Delivery planning should include neonatal bleeding risk, vitamin K, seizure continuity, and a postpartum dose review rather than waiting for toxicity or breakthrough seizures.

Frequently asked questions

What is fetal hydantoin syndrome?

Fetal hydantoin syndrome is a reported pattern after prenatal phenytoin exposure that can include distinctive skull and facial features, underdeveloped nails or fingertips, reduced growth, small head size, and neurodevelopmental differences. Not every exposed baby has this pattern, and older studies used inconsistent definitions.

What is the chance of a birth defect from phenytoin?

No single percentage fits every phenytoin pregnancy. The Dilantin label cites observational meta-analyses estimating about a 2.4-fold relative increase in major malformations versus controls, while one registry analysis reported 2.9 percent and substantial statistical uncertainty. Dose, other medicines, seizure disorder, and study design affect estimates.

Should I stop Dilantin when I find out I am pregnant?

Do not stop Dilantin abruptly after a positive pregnancy test. The medication guide warns that sudden withdrawal can cause more frequent seizures or status epilepticus. Call the prescribing neurologist and obstetric clinician promptly so any change protects both seizure control and fetal outcomes.

Why is folic acid recommended with phenytoin?

The joint AAN, AES, and SMFM guideline recommends at least 0.4 mg folic acid daily before conception and during pregnancy for people taking any antiseizure medicine, mainly for neural-tube and possible neurodevelopmental benefit. The optimal dose is unknown, and folic acid can alter phenytoin levels, so dosing needs clinician oversight.

Do I need high-dose folic acid with phenytoin?

A universal high-dose folic acid rule is not supported by the current U.S. joint guideline. It recommends at least 0.4 mg daily and says evidence does not identify an optimal higher dose. Your neurologist and obstetric clinician may individualize the amount based on history, diet, and interacting medicines.

Is there a safe dose of phenytoin during pregnancy?

Research does not establish a phenytoin dose with zero fetal risk. The goal is the lowest regimen that reliably controls the relevant seizure type, guided by symptoms and blood levels. Changing the dose without supervision can produce toxicity or breakthrough seizures.

Why are phenytoin blood levels checked during pregnancy?

Pregnancy can increase phenytoin clearance and lower measured concentrations, sometimes worsening seizure control. Protein binding also changes, so the clinically useful test may include free phenytoin rather than total level alone. Monitoring timing and targets should follow the neurologist's individualized plan.

Does phenytoin exposure require extra fetal monitoring?

Phenytoin exposure warrants coordinated obstetric and neurology planning. The ultrasound and growth-monitoring schedule depends on timing, dose, other antiseizure medicines, seizure control, and medical history. Normal imaging cannot exclude every developmental effect.

Why does vitamin K come up near delivery with Dilantin?

The Dilantin label describes a potentially serious newborn bleeding disorder related to low vitamin K-dependent clotting factors after prenatal phenytoin exposure. Delivery teams should know about the medicine so maternal and newborn vitamin K planning and newborn observation are arranged rather than improvised.

Can I enroll in a pregnancy registry for phenytoin?

The Dilantin label directs pregnant patients to the North American Antiepileptic Drug Pregnancy Registry. Enrollment collects outcome data but does not replace clinical care. Ask your neurology or obstetric team for the current registry contact information and how participation fits your follow-up.

Related in the library

References

  1. DILANTIN (extended phenytoin sodium capsules), for oral use

    DailyMed · https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=f5b7e576-49b1-4633-ab0a-6ab94922e970&type=display

  4. Management of epilepsy during pregnancy

    PubMed Central · https://pmc.ncbi.nlm.nih.gov/articles/PMC6411070/

  5. DILANTIN (extended phenytoin sodium capsules), for oral use

    DailyMed · https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=86dd27d1-9cee-48ae-b55d-e2d2f7dbc593&type=pdf

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.